Gerd A. Kullak‐Ublick
Novartis (Switzerland)(CH)University of Zurich(CH)University Hospital of Zurich(CH)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Drug-Induced Hepatotoxicity and Protection, Liver Disease Diagnosis and Treatment, Pharmacological Effects and Toxicity Studies, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci(2010)2,560 cited
- → Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME(2013)1,260 cited
- → EASL Clinical Practice Guidelines: Drug-induced liver injury(2019)1,078 cited
- → Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection(2020)1,046 cited
- → Drug-induced liver injury(2019)751 cited
- → Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver(2001)719 cited